Company Description
Heartbeam (NASDAQ: BEATW) is a publicly traded company in the Surgical & Medical Instruments & Apparatus sector.
BEATW stock has declined 87.6% over the past year. Shares last traded at $0.0326.
On a trailing twelve-month basis, Heartbeam reported net income of -$21.0M and diluted earnings per share of $-0.62.
This page provides a comprehensive overview of BEATW stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Heartbeam (BEATW) stock last traded at $0.0326, up 8.67% from the previous close. Over the past 12 months, the stock has lost 87.6%.
BEATW Rankings
Latest News
SEC Filings
Heartbeam has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form DEF 14A, 1 Form 10-Q. The most recent filing was submitted on July 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BEATW SEC filings →
Financial Highlights
operating income reached -$21.1M, and net income was -$21.0M. Diluted earnings per share stood at $-0.62. The company generated -$14.0M in operating cash flow. With a current ratio of 1.45, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Heartbeam (BEATW) currently stands at 483 shares, down 83.8% from the previous reporting period. Over the past 12 months, short interest has increased by 425.0%.
Days to Cover History
Days to cover for Heartbeam (BEATW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 4.0 days.
BEATW Company Profile & Sector Positioning
Heartbeam (BEATW) operates in the Surgical & Medical Instruments & Apparatus sector and is listed on the NASDAQ.